TipRanks
Advertisement
Advertisement
Lixte Biotechnology to acquire Nomad Transportable Power Systems
PremiumThe FlyLixte Biotechnology to acquire Nomad Transportable Power Systems
4M ago
Lixte Biotechnology Announces At-the-Market Equity Financing
Premium
Company Announcements
Lixte Biotechnology Announces At-the-Market Equity Financing
4M ago
Lixte Biotechnology Shifts Strategy to AI Energy Infrastructure
Premium
Company Announcements
Lixte Biotechnology Shifts Strategy to AI Energy Infrastructure
4M ago
LIXTE Biotechnology (NASDAQ: LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference
PremiumTipRanks NewswireLIXTE Biotechnology (NASDAQ: LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference
6M ago
Lixte Biotechnology presents preliminary LB100 results
Premium
The Fly
Lixte Biotechnology presents preliminary LB100 results
6M ago
Lixte Biotech Holdings (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships
Premium
TipRanks Newswire
Lixte Biotech Holdings (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships
6M ago
Lixte Biotech (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Position Through Liora Technologies Partnership
PremiumTipRanks NewswireLixte Biotech (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Position Through Liora Technologies Partnership
7M ago
Landmark Proton Therapy Data Changes the Conversation; LIXTE Biotechnology (NASDAQ: LIXT) Saw It Coming
Premium
TipRanks Newswire
Landmark Proton Therapy Data Changes the Conversation; LIXTE Biotechnology (NASDAQ: LIXT) Saw It Coming
7M ago
LIXTE Biotechnology (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape
Premium
TipRanks Newswire
LIXTE Biotechnology (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―